Translation dysregulation in cancer as a source for targetable antigens

Keyphrases

• In Cancer 100%
• Dysregulation 100%
• Translation Quality 100%
• Checkpoint Blockade 66%
• Tumor Immunogenicity 66%
• T Cells 33%
• Cell-based 33%
• Malignant Cells 33%
• Immunogenicity 33%
• Tumor Cells 33%
• Protein Synthesis 33%
• Dysregulated 33%
• Cancer Immunotherapy 33%
• Functional Assay 33%
• Transfer RNA (tRNA) 33%
• Immunogenic 33%
• Tumor Eradication 33%
• Genomic Assay 33%
• Major Histocompatibility Complex Molecules 33%
• Tumor Control 33%
• Programmed Death-ligand 1 (PD-L1) 33%
• Knockout Cells 33%
• Downstream Impacts 33%
• Immunopeptidomics 33%
• Wybutosine 33%

Biochemistry, Genetics and Molecular Biology

• T Cell 100%
• Tumor Immunogenicity 100%
• Drive 50%
• Protein Biosynthesis 50%
• Immunogenicity 50%
• Major Histocompatibility Complex 50%
• Cancer Immunotherapy 50%
• Genomics 50%
• Transfer RNA 50%
• Wybutosine 50%
• Programmed Cell Death 1 50%
• Immunopeptidomics 50%

Immunology and Microbiology

• Peptides 100%
• T Cell 50%
• Tumor Immunogenicity 50%
• Immunogenicity 25%
• Tumor Cell 25%
• Major Histocompatibility Complex 25%
• Cancer Immunotherapy 25%
• Programmed Cell Death 1 25%
• Transfer RNA 25%
• Immunopeptidomics 25%
• Protein Synthesis 25%